ArticleAmerican journal of translational research2024
Effect of Compound Xuejie Powder combined with negative pressure wound therapy on diabetic foot ulcers and blood flow in the dorsal foot artery.
Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo observe the therapeutic effect of Compound Xuejie Powder combined with negative pressure wound therapy (NPWT) on diabetic foot ulcers and its influence on the blood flow of the dorsal artery in the foot.
methodsA total of 103 patients with diabetic foot ulcers, admitted to our hospital between February 2021 and March 2023, were included in this study. The control group was given NPWT on the basis of conventional treatment such as controlling blood sugar and blood pressure, anti-infection therapy and improving blood circulation, while the observation group was given Compound Xuejie Powder combined with NPWT on the basis of conventional treatment. The two groups were compared in terms of granulation tissue coverage and thickness, wound healing time, levels of inflammatory factors related to Notch signaling pathway in wound exudation, serum angiogenesis factors, and dorsal foot artery blood flow.
resultsBefore treatment, there were no significant differences between the two groups in the levels of inflammatory factors related to the Notch signaling pathway in wound exudates or serum angiogenesis factors (all P>0.05). After treatment, vascular endothelial growth factor (VEGF) level increased, while the levels of TNF-α, IL-1β, IL-6, IL-17 and chemoattractant factor (pigment epithelium-derived factor, PEDF) decreased in both groups, an these alterations in the observation group were more pronounced compared to the control group (all P<0.05). There was no significant difference in dorsal foot artery blood flow before treatment (all P>0.05); however, Vm, PI, RI and vascular diameter were notably increased in both groups after the treatment, with more pronounced improvements noticed in the observation group (all P<0.05). The total effective rate, granulation tissue coverage rate, and granulation tissue thickness were significantly higher while wound healing time was significantly shorter in the observation group compared to the control group (all P<0.05).
conclusionIn the treatment of diabetic foot ulcers, Compound Xuejie Powder combined with NPWT can effectively inhibit local inflammation, improve the blood flow of the dorsal foot artery and promote ulcer healing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.